Alivus Life Sciences Ltd

NSE: ALIVUS · BSE: 543322 · Pharmaceuticals & Biotechnology · 23 announcements

Share price: ₹1,384.70
Market cap: ₹17,000 Cr
Revenue (annual): ₹2,552 Cr
Net profit (annual): ₹564.5 Cr
P/E (TTM): 28.2×Sector 47.4×
Promoter holding: 74.87%+0.00% QoQ
FII holding: 5.54%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Merger & Restructuring 2 Earnings Call 2 Annual General Meeting 2 Results Update 1 Financial Results 1 Employee Stock Options 1 Business Update 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

30 Jul 2026 19:11 IST BSE

Employee Stock Options

Alivus Life Sciences Employee Stock Options

Alivus Life Sciences allotted 32,000 equity shares under its Employee Stock Option Scheme, 2021. This increases the company's total paid-up share capital.

Read the filing ↗